A detailed history of Aqr Capital Management LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Aqr Capital Management LLC holds 964,950 shares of BSX stock, worth $96.8 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
964,950
Previous 702,218 37.41%
Holding current value
$96.8 Million
Previous $54.1 Million 49.53%
% of portfolio
0.11%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $19.2 Million - $22.1 Million
262,732 Added 37.41%
964,950 $80.9 Million
Q2 2024

Aug 14, 2024

SELL
$67.33 - $77.71 $10.2 Million - $11.8 Million
-151,474 Reduced 17.74%
702,218 $54.1 Million
Q1 2024

May 15, 2024

BUY
$57.6 - $68.62 $2.45 Million - $2.92 Million
42,585 Added 5.25%
853,692 $58.5 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $13.3 Million - $15.8 Million
273,955 Added 51.0%
811,107 $46.9 Million
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $3.44 Million - $3.74 Million
68,478 Added 14.61%
537,152 $28.4 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $10.4 Million - $11.4 Million
208,267 Added 79.98%
468,674 $25.4 Million
Q1 2023

May 15, 2023

BUY
$45.09 - $50.03 $1.5 Million - $1.67 Million
33,335 Added 14.68%
260,407 $13 Million
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $1.22 Million - $1.45 Million
30,797 Added 15.69%
227,072 $10.5 Million
Q3 2022

Nov 14, 2022

BUY
$36.71 - $109.66 $2.07 Million - $6.18 Million
56,342 Added 40.26%
196,275 $7.6 Million
Q2 2022

Aug 15, 2022

BUY
$35.24 - $47.1 $189,802 - $253,680
5,386 Added 4.0%
139,933 $5.2 Million
Q1 2022

May 16, 2022

SELL
$40.9 - $45.1 $7.82 Million - $8.63 Million
-191,259 Reduced 58.7%
134,547 $5.96 Million
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $1.88 Million - $2.21 Million
-49,312 Reduced 13.15%
325,806 $13.8 Million
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $4.18 Million - $4.65 Million
-101,272 Reduced 21.26%
375,118 $16.3 Million
Q2 2021

Aug 16, 2021

SELL
$38.58 - $44.24 $11.9 Million - $13.6 Million
-307,364 Reduced 39.22%
476,390 $20.4 Million
Q1 2021

May 17, 2021

SELL
$35.27 - $39.67 $27 Million - $30.3 Million
-764,411 Reduced 49.38%
783,754 $30.3 Million
Q4 2020

Feb 16, 2021

BUY
$33.15 - $41.97 $33.1 Million - $41.9 Million
998,933 Added 181.88%
1,548,165 $55.1 Million
Q3 2020

Nov 16, 2020

SELL
$34.44 - $42.23 $8.55 Million - $10.5 Million
-248,356 Reduced 31.14%
549,232 $20.8 Million
Q2 2020

Aug 17, 2020

BUY
$30.19 - $39.11 $11.9 Million - $15.4 Million
392,667 Added 96.97%
797,588 $27.4 Million
Q1 2020

May 15, 2020

BUY
$25.83 - $45.71 $4.18 Million - $7.4 Million
161,806 Added 66.56%
404,921 $13.2 Million
Q4 2019

Feb 14, 2020

SELL
$37.87 - $45.37 $3.12 Million - $3.74 Million
-82,479 Reduced 25.33%
243,115 $11 Million
Q3 2019

Nov 14, 2019

SELL
$40.31 - $43.45 $42.9 Million - $46.2 Million
-1,064,050 Reduced 76.57%
325,594 $13.2 Million
Q2 2019

Aug 14, 2019

SELL
$34.91 - $42.98 $34.1 Million - $42 Million
-977,065 Reduced 41.28%
1,389,644 $58.4 Million
Q1 2019

May 14, 2019

BUY
$32.91 - $40.75 $20.7 Million - $25.7 Million
629,852 Added 36.26%
2,366,709 $90.3 Million
Q4 2018

Feb 14, 2019

SELL
$31.73 - $39.04 $22.5 Million - $27.7 Million
-708,505 Reduced 28.97%
1,736,857 $61.4 Million
Q3 2018

Nov 15, 2018

SELL
$32.83 - $38.63 $7.13 Million - $8.39 Million
-217,266 Reduced 8.16%
2,445,362 $94.1 Million
Q2 2018

Aug 14, 2018

SELL
$26.84 - $34.32 $5.11 Million - $6.53 Million
-190,288 Reduced 6.67%
2,662,628 $87.1 Million
Q1 2018

May 15, 2018

BUY
$25.2 - $28.54 $2.33 Million - $2.63 Million
92,265 Added 3.34%
2,852,916 $77.9 Million
Q4 2017

Feb 14, 2018

BUY
$24.79 - $29.8 $35.3 Million - $42.5 Million
1,425,278 Added 106.73%
2,760,651 $68.4 Million
Q3 2017

Nov 14, 2017

BUY
$26.26 - $29.17 $35.1 Million - $39 Million
1,335,373
1,335,373 $39 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $144B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.